Get started
Author

Karen Giménez-Orenga

Observed names: Giménez-Orenga, Karen, Karen Giménez, Karen Giménez Orenga
ORCID: 0000-0001-9790-7327
Observed ORCID: 0000-0001-9790-7327
OpenAlex ID: A5047020154
Human Endogenous Retrovirus as Therapeutic Targets in Neurologic Disease
2021 · Karen Giménez-Orenga, Hervé Perron, et al. · Pharmaceuticals · 48
PDF
HERV-W ENV antigenemia and correlation of increased anti-SARS-CoV-2 immunoglobulin levels with post-COVID-19 symptoms
2022 · Karen Giménez-Orenga, Justine Pierquin, et al. · Frontiers in Immunology · 39
PDF
Advancing Research and Treatment: An Overview of Clinical Trials in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Future Perspectives
2024 · Katharine A. Seton, José A. Espejo-Oltra, et al. · Journal of Clinical Medicine · 36
PDF
MYC Induces a Hybrid Energetics Program Early in Cell Reprogramming
2018 · Javier Prieto, Arnold Y. Seo, et al. · Stem Cell Reports · 36
PDF
Diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome With Partial Least Squares Discriminant Analysis: Relevance of Blood Extracellular Vesicles
2022 · Alba González-Cebrián, Eloy Almenar-Pérez, et al. · Frontiers in Medicine · 13
HERV activation segregates ME/CFS from fibromyalgia while defining a novel nosologic entity
2025 · Karen Giménez-Orenga, Eva Martín-Martínez, et al. · eLife · 10
Detection and absolute quantitation of watermelon mosaic virus by real-time RT-PCR with a TaqMan probe
2021 · Luis Rubio, Karen Giménez, et al. · Journal of Virological Methods · 7
PDF
Blood parameters differentiate post COVID-19 condition from Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Fibromyalgia
2025 · Karen Giménez-Orenga, Justine Pierquin, et al. · Brain Behavior & Immunity - Health · 5
HERV activation segregates ME/CFS from fibromyalgia while defining a novel nosologic entity
2025 · Karen Giménez-Orenga, Eva Martín-Martínez, et al. · eLife · 3
Over-Representation of Torque Teno Mini Virus 9 in a Subgroup of Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Pilot Study
2024 · Karen Giménez Orenga, Eva Martín-Martínez, et al. · Pathogens · 3
PDF
Manual Therapy Improves Fibromyalgia Symptoms by Downregulating SIK1
2024 · Javier Bonastre-Férez, Karen Giménez-Orenga, et al. · International Journal of Molecular Sciences · 3
PDF
HERV Dysregulation in a Case of Myalgic Encephalomyelitis and Multiple Sclerosis Responsive to Rituximab
2025 · Eva Martín-Martínez, Sara Gil-Perotin, et al. · International Journal of Molecular Sciences · 2
PDF
Transposable Elements Shaping the Epigenome
2022 · Karen Giménez-Orenga, Elisa Oltra · Elsevier eBooks · 2
Multifaceted evolution focused on maximal exploitation of domain knowledge for the consensus inference of Gene Regulatory Networks
2025 · Adrián Segura-Ortiz, Karen Giménez-Orenga, et al. · Computers in Biology and Medicine · 1
Author response: HERV activation segregates ME/CFS from fibromyalgia while defining a novel nosologic entity
2025 · Karen Giménez-Orenga, Eva Martín-Martínez, et al.
Author response: HERV activation segregates ME/CFS from fibromyalgia while defining a novel nosologic entity
2025 · Karen Giménez-Orenga, Eva Martín-Martínez, et al.
HERV activation segregates ME/CFS from fibromyalgia while defining a novel nosologic entity
2025 · Karen Giménez-Orenga, Eva Martín-Martínez, et al. · eLife
HERV activation segregates ME/CFS from fibromyalgia while defining a novel nosologic entity
2025 · Karen Giménez-Orenga, Eva Martín-Martínez, et al. · eLife
Author response: HERV activation segregates ME/CFS from fibromyalgia while defining a novel nosologic entity
2025 · Karen Giménez-Orenga, Eva Martín-Martínez, et al.
PDF
List of contributors
2022 · Nobuyoshi Akimitsu, Marina Alexeeva, et al. · Elsevier eBooks
Human endogenous retrovirus and clinical treatments of neurological disease
2020 · Karen Giménez, Elisa Oltra · International Electronic Conference on Medicinal Chemistry (ECMC)
Works count: 22
Citation count: 208
H-index: 7
I10-index: 6
Year
Topic
Type